期刊文献+

白细胞介素-28B的基因多态性与干扰素抗丙型肝炎病毒治疗应答的关系 被引量:5

Relationship of interleukin 28B polymorphisms and response to interferon treatment in patients with hepatitis C infection
下载PDF
导出
摘要 目的探讨IL-28B基因多态性与慢性丙型肝炎患者对干扰素治疗应答的关系。方法采用分子生物学方法提取基因组DNA,PCR扩增后直接测序,对我院感染科门诊和住院的63例应答组(SVR)和34例无应答组(NVR)的HCV 1型患者的SNPs rs8099917和rs12980275位点进行检测分析。结果 (1)rs12980275只检测到AA、AG,rs8099917只检测到TT、TG,二者均未发现GG型。(2)rs12980275、rs8099917基因型分布在SVR组和NVR组之间差异均具有统计学意义(OR=3.288,95%CI=[1.171~9.234],χ2=5.416,P=0.020;OR=2.865,95%CI=[1.006~8.154],χ2=4.081,P=0.043)。(3)rs12980275等位基因频率在SVR组和NVR组之间差异具有统计学意义(OR=2.846,95%CI=[1.086~7.464],χ2=4.828,P=0.028);rs8099917等位基因频率在SVR组和NVR组之间差异无统计学意义(OR=2.543,95%CI=[0.953~6.785],χ2=3.664,P=0.056)。(4)rs12980275、rs8099917的基因型及等位基因频率在SVR、NVR组中的相关性分析r均大于0(r=0.236,r=0.205,r=0.158,r=0.137),均呈正相关。结论 rs12980275和rs8099917多态性对干扰素抗丙型肝炎病毒治疗应答有重要影响,可以预测抗病毒疗效,为实现个体化治疗提供依据。 Objective To determine the correlation between interleukin 28B(IL-28B) polymorphism in chronic hepatitis C patients and their response to interferon treatment.Methods A total of 97 cases of identified chronic hepatitis C 1 type,including 63 cases of sustained virological response(SVR) and 34 cases of null virological response(NVR),were collected from in-patient and out-patient of our department from 2009 to 2011.Their genomic DNA was extracted by molecular biology methods,and PCR directly sequencing was performed for SNPs genotyping of rs8099917 and rs12980275.The SNPs genotypes of the 2 sites were analyzed in the SVR and NVR group.Results Genotype of rs12980275 was only detected as AA,and AG,while that of rs8099917 was only TT and TG.There was no GG type found in both rs12980275 and rs8099917.Significant difference was found in the genotype distribution of rs12980275 and rs8099917 between the SVR group and NVR group(OR=3.288,95%CI=[1.171 to 9.234],Pearson's Chi square=5.416,P=0.020;OR=2.865;95%CI= [1.006 to 8.154],Pearson's Chi square=4.081,P=0.043).The frequencies of alleles of rs12980275 were significant difference between the 2 groups(OR=2.846,95%CI=[1.086 to 7.464],Pearson's Chi square=4.828,P=0.028).The frequencies of alleles of rs8099917 had no significant difference between the 2 groups(OR=2.543,95%CI=[0.953 to 6.785],Pearson's Chi square=3.664,P=0.056).The genotypes distribution and the frequencies of alleles of rs12980275 and rs8099917 had positive correlation between the 2 groups(Pearson's r=0.236;Pearson's r=0.205;Pearson's r=0.158;Pearson's r=0.137).Conclusion Polymorphism of SNPs rs8099917 and rs12980275 are associated with outcomes of patients' antiviral response to interferon.IL-28B genetic polymorphisms can provide a reliable basis for individual therapy and predicting treatment efficacy.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第9期832-835,共4页 Journal of Third Military Medical University
关键词 丙型肝炎病毒 单核苷酸多态性 IL-28B基因多态性 干扰素持续性病毒应答 hepatitis C virus single nucleotide polymorphism IL28B polymorphism interferon sustained virological response
  • 相关文献

参考文献15

  • 1Bowen D G, Walker C M. Adaptive immune responses in acute and chronic hepatitis C virus infection [ J ] . Nature, 2005, 436 (7053) : 946 - 952.
  • 2NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements, 2002, 19 (3) : 1 - 46.
  • 3石晓东,姜晶,牛俊奇.白细胞介素28B的基因多态性与丙型肝炎病毒感染转归的关系[J].临床肝胆病杂志,2011,27(1):28-31. 被引量:11
  • 4Ge D, Fellay J, Thompson A J, et al. Genetic variation in IL28B pre- dicts hepatitis C treatment-induced viral clearance[ J]. Nature, 2009, 461 (7265) : 399 -401.
  • 5Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C[J]. Nat Genet, 2009, 41(10): 1105 -1109.
  • 6Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy [J]. Nat Genet, 2009, 41(10) : 1100-1104.
  • 7Rauch A, Kutalik Z, Descombes P, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome- wide association study[ J]. Gastroenterology, 2010, 138 (4) : 1338 - 1345.
  • 8丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 9Ghany M G, Strader D B, Thomas D L, et al. Diagnosis, manage- ment, and treatment of hepatitis C : an update [ J ]. Hepatology, 2009, 49(4) : 1335 - 1374.
  • 10Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R [ J ]. Nat Immunol, 2003, 4 ( 1 ) : 63 - 68.

二级参考文献67

  • 1Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class lI eytokine receptor IL - 28R[ J]. Nat Immunol, 2003,4( 1 ) : 63 - 68.
  • 2Witte K, Gruetz G, Volk HD, et al. Despite IFN - lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines[ J ]. Genes Immun,2009, 10(8):702 -714.
  • 3O'Brien TR. Interferon- alfa, interferon- lambda and hepatitis C [ J]. Nat Genet,2009, 41 (10) : 1048 - 1050.
  • 4Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment- induced viral clearance[ J]. Nature, 2009,461 (7262) : 399 -401.
  • 5Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon - alpha and ribavirin therapy [ J ]. Nat Genet,2009, 41 (10) : 1100 - 1104.
  • 6Tanaka Y, Nishida N, Sugiyama M, et al. Genome - wide association of IL28B with response to pegylated interferon - alpha and ribavirin therapy for chronic hepatitis C [ J]. Nat Genet,2009, 41 (10) :1105 -1109.
  • 7Thomas DL, Martin MP, Ying Qi, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus [ J ]. Nature, 2009, 461 (7265) : 798 - 801.
  • 8Ghany MG, Strader DB, Seeff, LB, et al. Diagnosis, management, and treatment of hepatitis C : an update [ J ]. Hepatology, 2009, 49 (4): 1335 - 1374.
  • 9Sarasin- Filipowicz M, Oakeley EJ, Duong FHT, et al. Interferon signaling and treatment outcome in chronic hepatitis C [ J]. Proc Natl Acad Sci U S A, 2008,105 ( 19 ) : 7034 - 7039.
  • 10World Health Organization. Hepatitis C 2009, http://www. who.int/mediacentre/factsheets/fs164/cn. 2002 Nov; 36(5 Suppl 1): S35-46.

共引文献773

同被引文献59

  • 1丙型肝炎防治指南[J].中华内科杂志,2004,43(7):551-555. 被引量:106
  • 2Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection[J]. Lancet Infect Dis, 2005, 5 (9) : 558-567.
  • 3European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection [J]. J Hepatol, 2011, 55 (2):245-264.
  • 4Ge D, Fellay J, Thompson A3, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J]. Nature, 2009, 461 (7262):399-401.
  • 5Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dote GJ, Powell E, Riordan S,Sheridan D, Smedile A, Fragomeli V, Muller T, Bahlo M, Stewart GJ, Booth DR, George J. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy [J]. Nat Genet, 2009,41 (10) :1100-1104.
  • 6Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K. Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, lto Y, Mita E, Tanaka E, Mochida S, Murawaki Y, ttonda M. Sakai A. ttiasa Y. Nishiguchi S, Koike A,Sakaida I, Imamura M, lto K, Yano K, Masaki N,Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon- alpha and ribavirin therapy for chronic hepatitis C [J].Nat Genet, 2009, 41 (10): 1105-1109.
  • 7Thomas DE., Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM,Rosen HR, Tobler EH, Busch MP, McHutchison JG, Goldstein DB, Carrington M. Genetic variation in IE28B and spontaneous clearance of hepatitis C virus [J]. Nature, 2009, 461 (7265):798-801.
  • 8Grandi T, da Silva CM, Amaral KM, Picon PD, Costi C, da Fre NN, Fiegenbaum M, Niel C, Rossetti ML. Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene[J]. Mem Inst Oswaldo Cruz, 2013, 108(1) :48-53.
  • 9Jimenez-Sousa MA, Ferndndez-Rodriguez A, Guzman- Fulgencio M, Garcla-dlvarez M, Resino S. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C [J].BMC Med, 2013,11:6. doi: 10.1186/1741-7015-11-6.
  • 10Rao HY, Sun DG, Jiang D, Yang RF, Guo F, Wang JH, Liu F, Zhang HY, Zhang HH, Du SC, Jin Q, Qin H, Lok AS, Wei L. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection [J]. J Viral Hepat, 2012,19 (3):173-181.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部